Tau Polyclonal Antibody

MAPT encodes the microtubule-associated protein tau (MAPT) whose transcript undergoes complex, regulated alternative splicing, giving rise to several mRNA species. MAPT transcripts are differentially expressed in the nervous system, depending on stage of neuronal maturation and neuron type. MAPT gene mutations have been associated with several neurodegenerative disorders such as Alzheimer's disease, Pick's disease, frontotemporal dementia, cortico-basal degeneration and progressive supranuclear palsy.

The TAU Polyclonal Antibody is a meticulously crafted and highly specific immunological tool designed to facilitate advanced research in the field of neurobiology. This antibody is derived from a diverse pool of immunized animals, ensuring a broad spectrum of binding capabilities and enhanced sensitivity. With its exceptional affinity for TAU protein, this antibody enables precise detection and quantification of TAU expression levels in various biological samples.

The TAU Polyclonal Antibody boasts an unparalleled level of purity and quality, meticulously purified through a rigorous process to eliminate any potential contaminants or impurities. This ensures optimal performance and reliability, allowing researchers to confidently explore the intricate mechanisms underlying TAU protein function.

This antibody exhibits exceptional versatility, making it suitable for a wide range of applications, including immunohistochemistry, western blotting, and immunofluorescence. Its robust performance across multiple experimental techniques enables comprehensive investigation of TAU protein dynamics and localization within cellular and tissue contexts.

Furthermore, the TAU Polyclonal Antibody demonstrates remarkable specificity, exhibiting minimal cross-reactivity with other proteins, thereby minimizing the risk of false-positive results. This specificity, combined with its high sensitivity, empowers researchers to accurately discern subtle changes in TAU expression and distribution, facilitating the elucidation of TAU-associated pathologies and potential therapeutic targets.

The TAU Polyclonal Antibody is supplied in a convenient and user-friendly format, ensuring ease of use and compatibility with various laboratory protocols. Each vial is meticulously packaged and accompanied by comprehensive instructions, guaranteeing optimal handling and storage conditions to maintain antibody integrity and performance.

In summary, the TAU Polyclonal Antibody represents a cutting-edge immunological tool meticulously designed to empower researchers in their quest to unravel the complexities of TAU protein biology. With its exceptional specificity, sensitivity, and versatility, this antibody is poised to revolutionize neurobiological research and contribute to the advancement of therapeutic interventions targeting TAU-associated disorders.